10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,043,614 | -5.3% | 98,027 | +28.1% | 0.00% | 0.0% |
| Q2 2023 | $4,271,928 | -5.8% | 76,503 | -5.9% | 0.00% | -33.3% |
| Q1 2023 | $4,536,508 | +42.7% | 81,314 | -6.3% | 0.00% | +50.0% |
| Q4 2022 | $3,178,540 | +15.3% | 86,770 | -5.9% | 0.00% | 0.0% |
| Q3 2022 | $2,756,127 | +44.3% | 92,236 | +122.7% | 0.00% | +100.0% |
| Q2 2022 | $1,910,261 | -20.8% | 41,413 | +28.5% | 0.00% | -50.0% |
| Q1 2022 | $2,412,203 | +704.1% | 32,219 | +1519.9% | 0.00% | – |
| Q4 2021 | $300,000 | +2.7% | 1,989 | -1.0% | 0.00% | – |
| Q3 2021 | $292,000 | -97.7% | 2,009 | -96.9% | 0.00% | -100.0% |
| Q2 2021 | $12,730,000 | +8.9% | 65,011 | +0.7% | 0.01% | 0.0% |
| Q1 2021 | $11,688,000 | +28.1% | 64,574 | +0.2% | 0.01% | +25.0% |
| Q4 2020 | $9,125,000 | +496.4% | 64,442 | +424.9% | 0.01% | +300.0% |
| Q3 2020 | $1,530,000 | – | 12,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |